See more : China BlueChemical Ltd. (3983.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Bacil Pharma Limited (BACPHAR.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bacil Pharma Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- DuoLun Technology Corporation Ltd. (603528.SS) Income Statement Analysis – Financial Results
- Black Diamond Group Limited (BDIMF) Income Statement Analysis – Financial Results
- Equatorial Pará Distribuidora de Energia S.A. (EQPA5.SA) Income Statement Analysis – Financial Results
- American Aires Inc. (A5A.F) Income Statement Analysis – Financial Results
- Serabi Gold plc (SRB.L) Income Statement Analysis – Financial Results
Bacil Pharma Limited (BACPHAR.BO)
About Bacil Pharma Limited
Bacil Pharma Ltd. engages in the manufacture and sale of pharmaceuticals, medicinal, and botanical products. Its manufacturing plant is in Lote-Parshuram, which also have facility for herbal extracts and drug intermediates. The company was founded on May 8, 1987 is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.64M | 4.60M | 55.50K | 128.00K | 1.62M | 2.66M |
| Cost of Revenue | 19.95K | 26.92K | 37.17K | 49.31K | 82.24K | 90.99K | 102.43K | 32.35K | 7.84K | 0.00 | 0.00 | 9.14M | 3.90M | 0.00 | 0.00 | 1.40M | 2.34M |
| Gross Profit | -19.95K | -26.92K | -37.17K | -49.31K | -82.24K | -90.99K | -102.43K | -32.35K | -7.84K | 0.00 | 0.00 | 1.50M | 700.00K | 55.50K | 128.00K | 222.00K | 314.00K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 14.06% | 15.22% | 100.00% | 100.00% | 13.69% | 11.83% |
| Research & Development | 0.00 | 0.00 | 0.00 | 86.06K | 64.42K | 0.00 | 37.30K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 129.71K | 157.55K | 132.25K | 168.25K | 390.72K | 349.96K | 155.11K | 451.44K | 311.29K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.87M | 129.71K | 157.55K | 132.25K | 168.25K | 390.72K | 349.96K | 155.11K | 451.44K | 311.29K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 1.15M | 576.00K | 739.00K | 12.00 | -350.54K | -128.84K | 475.00K | 0.00 | 315.00K | 230.00K | 0.00 | 90.00K | 300.00K | 120.00K | 0.00 | 0.00 |
| Operating Expenses | 1.87M | 1.77M | 1.59M | 1.37M | 1.89M | 2.63M | 2.94M | 1.72M | 853.02K | 500.28K | 1.65M | 1.82M | 262.67K | 507.72K | 490.96K | 587.00K | 301.00K |
| Cost & Expenses | 1.89M | 1.77M | 1.59M | 1.37M | 1.89M | 2.63M | 2.94M | 1.72M | 853.02K | 500.28K | 1.65M | 10.96M | 4.16M | 507.72K | 490.96K | 1.99M | 2.64M |
| Interest Income | 0.00 | 270.32K | 575.55K | 733.09K | 1.42M | 926.70K | 273.62K | 180.00K | 182.45K | 182.44K | 328.32K | 110.51K | 0.00 | 95.00K | 9.37K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 14.17K | 8.17K | 45.60K | 93.15K | 2.32K | 236.12K | 786.00 | 742.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 19.95K | 26.92K | 37.17K | 49.31K | 82.24K | 90.99K | 102.43K | 32.35K | 7.84K | 38.51K | 56.29K | 7.43K | -90.00K | -395.00K | -129.37K | 0.00 | 0.00 |
| EBITDA | -569.32K | -991.17K | -38.56M | -2.35M | -3.07M | -3.34M | -37.40M | 12.49K | -661.99K | -279.34K | -1.03M | -207.18K | 437.33K | -452.22K | -362.96K | -365.00K | 13.00K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2.99% | 9.51% | -814.80% | -283.56% | -22.50% | 0.49% |
| Operating Income | -1.89M | -1.81M | -1.59M | -1.71M | -1.98M | -2.78M | -3.29M | -20.64K | -670.57K | -318.12K | -1.09M | -214.60K | 527.33K | -57.22K | -233.59K | -365.00K | 13.00K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2.02% | 11.46% | -103.09% | -182.49% | -22.50% | 0.49% |
| Total Other Income/Expenses | 1.30M | 791.54K | -37.01M | -685.83K | -1.18M | -652.82K | -34.22M | 1.69M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 262.36K | 0.00 | 0.00 |
| Income Before Tax | -589.81K | -1.02M | -38.60M | -2.40M | -3.16M | -3.43M | -37.51M | -20.64K | -670.57K | -318.12K | -1.09M | -214.60K | 527.33K | -57.22K | -233.59K | -365.00K | 13.00K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2.02% | 11.46% | -103.09% | -182.49% | -22.50% | 0.49% |
| Income Tax Expense | 720.00 | -357.00 | -2.18K | -4.35K | -4.04K | -11.14K | -13.58K | 463.71K | 259.80K | -182.16K | -558.32K | 20.00K | 81.47K | 0.00 | 5.50K | 5.00K | 10.00K |
| Net Income | -590.53K | -1.02M | -38.60M | -2.39M | -3.15M | -3.42M | -37.50M | -20.64K | -670.57K | -318.12K | -1.09M | -234.60K | 445.86K | -57.22K | -233.59K | -370.00K | 3.00K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2.21% | 9.69% | -103.09% | -182.49% | -22.81% | 0.11% |
| EPS | -0.10 | -0.17 | -6.55 | -0.41 | -0.54 | -0.58 | -6.37 | 0.00 | -0.11 | -0.05 | -0.19 | -0.04 | 0.07 | -0.01 | -0.04 | -0.06 | 0.00 |
| EPS Diluted | -0.10 | -0.17 | -6.55 | -0.41 | -0.54 | -0.58 | -6.37 | 0.00 | -0.11 | -0.05 | -0.19 | -0.04 | 0.07 | -0.01 | -0.04 | -0.06 | 0.00 |
| Weighted Avg Shares Out | 5.89M | 5.89M | 5.89M | 5.89M | 5.89M | 5.89M | 5.89M | 5.89M | 5.89M | 6.36M | 5.74M | 5.87M | 6.37M | 5.89M | 5.89M | 5.89M | 0.00 |
| Weighted Avg Shares Out (Dil) | 5.89M | 5.89M | 5.89M | 5.89M | 5.89M | 5.90M | 5.89M | 5.89M | 6.10M | 6.36M | 5.74M | 5.87M | 6.37M | 5.89M | 5.89M | 5.89M | 0.00 |
No news found for: BACPHAR.BO
Source: https://incomestatements.info
Category: Stock Reports